Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Study of Relationship of Plasma Concentrations of Folic Acid, Vitamin B and Homocysteine With Carotid Atherosclerosis and Endothelium-Dependent Vasodilatation of Geriatric and Young Patients in the Ambulatory Care Department of NTUH
This study has been completed.
Sponsored by: National Taiwan University Hospital
Information provided by: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT00172250
  Purpose

Elevation of plasma homocysteine has been recognized as one of the risk factors of atherosclerotic disease. The objectives of this study are: (1) to investigate the level of plasma homocysteine and the prevalence of hypehomocysteinemia (2) to find out the role of homocysteine in coronary artery disease and the proper cut-off point of plasma homocysteine to evaluate the presence of coronary artery disease; (3) to understand the control condition of tranditional risk factors of cardiovascular disease, especially hypertension, dyslipidemia, and diabetes mellitus.

The study subjects were recruited from the ambulatory setting of cardiology in National Taiwan University Hospital.


Condition
Homocysteine
Coronary Artery Disease

MedlinePlus related topics: Coronary Artery Disease
Drug Information available for: Folic acid Homocysteine
U.S. FDA Resources
Study Type: Observational
Study Design: Screening, Cross-Sectional, Case Control, Retrospective Study

Further study details as provided by National Taiwan University Hospital:

Study Start Date: September 2003
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

Patient > 65 y/o or < 50y/o Scr<=1.5mg/dL

Exclusion Criteria:

  • Scr> 1.5mg/dl pregnancy alcohoism
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00172250

Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: Juey-Jen Hwang, MD, PhD National Taiwan University Hospital
  More Information

Study ID Numbers: 9261701046
Study First Received: September 12, 2005
Last Updated: November 23, 2005
ClinicalTrials.gov Identifier: NCT00172250  
Health Authority: Taiwan: Department of Health

Study placed in the following topic categories:
Atherosclerosis
Arterial Occlusive Diseases
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Central Nervous System Diseases
Ischemia
Arteriosclerosis
Brain Diseases
Cerebrovascular Disorders
Folic Acid
Coronary Disease
Carotid Artery Diseases
Coronary Artery Disease

Additional relevant MeSH terms:
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009